Telmisartan: all 179 studies that test it

Page 2 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy SubjectsCompletedNCT02203500Phase 1
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200653Phase 4
• A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT02200640Phase 4
• Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCompletedNCT02193308Phase 1
• Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy SubjectsCompletedNCT02187536Phase 1
• Relative Oral Bioavailability of Telmisartan / Hydrochlorothiazide (HCTZ) Fixed Dose Combination (FDC) Compared With Its Monocomponents in Healthy SubjectsCompletedNCT02187523Phase 1
• BIBR 277 Capsules in Hypertensive Patients With NephropathyCompletedNCT02187484Phase 2
• Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential HypertensionCompletedNCT02183701Phase 3
• Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan MonotherapyCompletedNCT02177500Phase 3
• Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate HypertensionCompletedNCT02177487Phase 3
• Telmisartan Compared With Enalapril in Elderly Patients With Blood HypertensionCompletedNCT02177461Phase 4
• BIBR 277 Capsule in Patients With Essential HypertensionCompletedNCT02177448Phase 3
• Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate HypertensionCompletedNCT02177435Phase 3
• Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate HypertensionCompletedNCT02177422Phase 3
• Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate HypertensionCompletedNCT02177409Phase 3
• MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure MonitoringCompletedNCT02177396Phase 3
• Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive PatientsCompletedNCT02172586Phase 4
• Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV InfectionCompletedNCT02170246Phase 1
• Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)CompletedNCT02152969Phase 1
• Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With HyperlipidemiaStatus unknownNCT02087540Phase 3
• Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease PatientsTerminatedNCT02085265Phase 2
• Comparative Study of the Effects of Telmisartan and NebivololStatus unknownNCT02057328Phase 4
• CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)CompletedNCT02047175Phase 1
• Non-invasive Haemodynamic Assessment in HypertensionCompletedNCT01996085Not applicable
• Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineCompletedNCT01842230Phase 1
• HIGH Altitude CArdiovascular REsearch in the ANDESCompletedNCT01830530Phase 4
• Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic SyndromeCompletedNCT01819220Phase 4
• Pharmacokinetic Interactions and Safety Study of Telmisartan and ChlorthalidoneCompletedNCT01806363Phase 1
• Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic AneurysmsCompletedNCT01683084Phase 4
• The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on ProteinuriaCompletedNCT01541267Phase 4
• Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AFCompletedNCT01435161Phase 4
• CKD-828 Drug Interaction Study (Telmisartan)CompletedNCT01356017Phase 1
• Use of Telmisartan and Captopril in Inflammation of Hemodialysis PatientsCompletedNCT01271478Phase 4
• Telmisartan Versus Losartan in Kidney TransplantationCompletedNCT01224860Phase 2
• Telmisartan, Amlodipine and Flow Mediated DilationStatus unknownNCT01180205Phase 4
• CKD-828 Primary Hypertension Trial(Dose-selection)CompletedNCT01128322Phase 2
• A Trial of Telmisartan Prevention of Cardiovascular DiseaseCompletedNCT01075698Phase 4
• The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic SyndromeCompletedNCT00926341Phase 4
• Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive PatientsTerminatedNCT00863980Not applicable
• Study Evaluating the Efficacy of Nifedipine GITS - Telmisartan Combination in Blood Pressure Control.CompletedNCT00750113Phase 4
• Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With NephropathyCompletedNCT00738660Phase 3
• Telmisartan Versus Ramipril After Acute Coronary SyndromeStatus unknownNCT00702936Phase 4
• Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in DiabetesCompletedNCT00599885Phase 4
• Nt-proBNP Guided Primary Prevention of CV Events in Diabetic PatientsCompletedNCT00562952Phase 2/3
• Regulation of Inflammatory Parameters by Telmisartan in Hypertensive PatientsCompletedNCT00560430Phase 3
• Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood VesselsTerminatedNCT00559286Phase 4
• A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsCompletedNCT00538486Phase 4
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on AmlodipineCompletedNCT00509470Phase 4
• Telmisartan in Haemodialysis Patients With Chronic Heart FailureCompletedNCT00490958Phase 4
• Telmisartan and Renal Perfusion in Patients With Metabolic SyndromeCompletedNCT00452192Phase 3
• Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS StudyCompletedNCT00421863Phase 4
• Telmisartan and Losartan in Hypertensive IGTCompletedNCT00407862Phase 4
• Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With HypertensionCompletedNCT00326768Phase 3
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and HypercholesterolemiaCompletedNCT00316095Phase 3
• Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese PatientsStatus unknownNCT00288717Not applicable
• Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281593Phase 3
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT00274638Phase 4
• Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPMCompletedNCT00274612Phase 4
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTNCompletedNCT00274599Phase 4
• Inflammation and Coronary Artery Disease: Role of AT1-Receptor AntagonismCompletedNCT00274144Phase 4
• DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilCompletedNCT00274118Phase 3
• SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk PatientsTerminatedNCT00274105Phase 4
• Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive PatientsCompletedNCT00267943Phase 3
• Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionCompletedNCT00257491Phase 3
• Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma ActivitiesCompletedNCT00242814Phase 4
• A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)CompletedNCT00240474Phase 4
• A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II PatientsCompletedNCT00240448Phase 4
• Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 DiabetesCompletedNCT00240422Phase 4
• Treatment of Insulin Resistance in Hypertensive, Obese AdolescentsTerminatedNCT00185705Not applicable
• A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)CompletedNCT00168857Phase 4
• Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 HypertensionCompletedNCT00168779Phase 4
• INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic NephropathyCompletedNCT00153088Phase 4
• 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential HypertensionCompletedNCT00153049Phase 2
• 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt NephropathyCompletedNCT00153023Phase 4
• Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mgCompletedNCT00146341Phase 3
• The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive SubjectsCompletedNCT00146289Phase 2
• Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan MonotherapyCompletedNCT00144222Phase 3
• A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate HypertensionCompletedNCT00133185Phase 3
• Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed DoseCompletedNCT00034840Phase 4

← Telmisartan overview